# JDZG (Jiade Limited) - SEC EDGAR Financial Statements

> Jiade Limited reported ¥25.70M in revenue and a net loss of ¥10.60M for the fiscal year ended December 31, 2025 (up 37.1% year over year), with a 45.4% gross margin and a -47.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/JDZG
- Markdown: https://convexityos.com/fundamentals/JDZG.md
- SEC CIK: 0001976908
- Reporting currency: CNY
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001976908&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | ¥25.70M | +37.1% YoY |
| Operating Income | FY 2025 | -¥12.22M | -47.6% margin |
| Net Income | FY 2025 | -¥10.60M | -41.2% net margin |
| Diluted EPS | FY 2025 | -¥38.44 | Split-adjusted |
| Free Cash Flow | FY 2025 | -¥4.46M | -17.3% FCF margin |
| Cash & ST Investments | Dec 31, 2025 | ¥19.77M | Total debt: ¥963K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | ¥25.70M | ¥18.74M | ¥15.57M | ¥10.24M |
| Cost of Revenue | ¥14.05M | ¥5.66M | ¥813K | ¥1.40M |
| **Gross Profit** | ¥11.66M | ¥13.08M | ¥14.76M | ¥8.84M |
| Research & Development | ¥2.14M | ¥710K | ¥696K | ¥379K |
| Selling, General & Admin | ¥21.74M | ¥5.99M | ¥2.49M | ¥2.41M |
| Total Operating Expenses | ¥23.88M | ¥6.70M | ¥3.19M | ¥2.79M |
| **Operating Income** | -¥12.22M | ¥6.39M | ¥11.57M | ¥6.05M |
| **EBITDA** | -¥9.63M | ¥6.72M | ¥11.78M | ¥6.33M |
| Interest Income | ¥843 | ¥18K | ¥2.3K | ¥101 |
| Interest Expense | ¥302K | ¥108K | ¥65K | ¥12K |
| Income Before Tax | -¥10.71M | ¥6.15M | ¥11.11M | ¥6.25M |
| Income Tax Expense | -¥186K | ¥546K | ¥1.55M | ¥887K |
| **Net Income** | -¥10.60M | ¥5.60M | ¥9.48M | ¥5.32M |
| Basic EPS | -¥38.44 | ¥45.67 | ¥85.30 | ¥384.00 |
| **Diluted EPS** | -¥38.44 | ¥45.67 | ¥85.30 | ¥384.00 |
| Basic Shares Outstanding | 275.7K | 122.7K | 111.2K | 13.9K |
| Diluted Shares Outstanding | 275.7K | 122.7K | 111.2K | 13.9K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | ¥19.77M | ¥3.92M | ¥7.08M |
| **Cash & Short-Term Investments** | ¥19.77M | ¥3.92M | ¥7.08M |
| Accounts Receivable, Net | ¥6.26M | ¥10.56M | ¥7.82M |
| Other Current Assets | ¥1.94M | ¥202K | ¥34K |
| **Total Current Assets** | ¥87.90M | ¥31.03M | ¥22.81M |
| Property, Plant & Equipment, Net | ¥4.26M | ¥581K | ¥160K |
| Goodwill | ¥26.55M | -- | -- |
| Intangible Assets | ¥24.04M | ¥16.94M | ¥1.99M |
| Other Non-Current Assets | -- | -- | ¥68K |
| **Total Non-Current Assets** | ¥56.05M | ¥50.31M | ¥2.42M |
| **Total Assets** | ¥144.0M | ¥81.33M | ¥25.23M |
| Accounts Payable | -- | -- | ¥1.6K |
| Deferred Revenue (Current) | ¥41K | ¥620K | ¥58K |
| Other Current Liabilities | ¥463K | ¥275K | -- |
| **Total Current Liabilities** | ¥21.74M | ¥9.76M | ¥7.41M |
| **Total Non-Current Liabilities** | ¥1.48M | ¥271K | ¥0 |
| **Total Liabilities** | ¥23.22M | ¥10.04M | ¥7.41M |
| **Total Debt (incl. Leases)** | ¥963K | ¥768K | ¥153K |
| Common Stock | -- | ¥1.71M | ¥1.54M |
| Retained Earnings | ¥7.84M | ¥18.49M | ¥13.45M |
| Accumulated Other Comp. Income | -¥1.09M | ¥418K | -- |
| **Total Stockholders' Equity** | ¥120.6M | ¥71.15M | ¥17.68M |
| Total Equity | ¥120.7M | ¥71.30M | ¥17.82M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | ¥19.77M | ¥3.92M | ¥7.08M |
| **Cash & Short-Term Investments** | ¥19.77M | ¥3.92M | ¥7.08M |
| Accounts Receivable, Net | ¥6.26M | ¥10.56M | ¥7.82M |
| Other Current Assets | ¥1.94M | ¥202K | ¥34K |
| **Total Current Assets** | ¥87.90M | ¥31.03M | ¥22.81M |
| Property, Plant & Equipment, Net | ¥4.26M | ¥581K | ¥160K |
| Goodwill | ¥26.55M | -- | -- |
| Intangible Assets | ¥24.04M | ¥16.94M | ¥1.99M |
| Other Non-Current Assets | -- | -- | ¥68K |
| **Total Non-Current Assets** | ¥56.05M | ¥50.31M | ¥2.42M |
| **Total Assets** | ¥144.0M | ¥81.33M | ¥25.23M |
| Accounts Payable | -- | -- | ¥1.6K |
| Deferred Revenue (Current) | ¥41K | ¥620K | ¥58K |
| Other Current Liabilities | ¥463K | ¥275K | -- |
| **Total Current Liabilities** | ¥21.74M | ¥9.76M | ¥7.41M |
| **Total Non-Current Liabilities** | ¥1.48M | ¥271K | ¥0 |
| **Total Liabilities** | ¥23.22M | ¥10.04M | ¥7.41M |
| **Total Debt (incl. Leases)** | ¥963K | ¥768K | ¥153K |
| Common Stock | -- | ¥1.71M | ¥1.54M |
| Retained Earnings | ¥7.84M | ¥18.49M | ¥13.45M |
| Accumulated Other Comp. Income | -¥1.09M | ¥418K | -- |
| **Total Stockholders' Equity** | ¥120.6M | ¥71.15M | ¥17.68M |
| Total Equity | ¥120.7M | ¥71.30M | ¥17.82M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -¥10.53M | ¥5.61M | ¥9.56M | ¥5.36M |
| Depreciation & Amortization | ¥2.59M | ¥331K | ¥213K | ¥281K |
| Stock-Based Compensation | ¥6.26M | -- | -- | -- |
| Change in Receivables | ¥3.52M | -¥2.85M | -¥1.42M | -¥6.27M |
| Change in Payables | -- | -¥1.6K | -¥178K | -¥276K |
| **Operating Cash Flow** | -¥93K | -¥5.05M | ¥10.38M | ¥495K |
| Capital Expenditure | -¥4.36M | -¥593K | -¥6.3K | -¥489K |
| **Free Cash Flow** | -¥4.46M | -¥5.64M | ¥10.37M | ¥6.6K |
| Acquisitions, Net | ¥446K | -¥32.00M | -- | -- |
| **Investing Cash Flow** | -¥55.95M | -¥47.71M | -¥1.79M | -¥549K |
| Common Stock Issued | -- | ¥66.44M | -- | -- |
| **Financing Cash Flow** | ¥71.91M | ¥49.37M | -¥4.11M | ¥2.65M |
| **Net Change in Cash** | ¥15.86M | -¥3.16M | ¥4.48M | ¥2.60M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 45.4% | 69.8% | 94.8% | 86.3% |
| **Operating Margin** | -47.6% | 34.1% | 74.3% | 59.1% |
| **Net Profit Margin** | -41.2% | 29.9% | 60.9% | 51.9% |
| Return on Equity (ROE) | -8.8% | 7.9% | 53.7% | -- |
| Return on Assets (ROA) | -7.4% | 6.9% | 37.6% | -- |
| Current Ratio | 4.04x | 3.18x | 3.08x | -- |
| Quick Ratio | 1.20x | 1.48x | 2.01x | -- |
| Debt to Equity | 0.01x | 0.01x | 0.01x | -- |
| **Revenue Growth (YoY)** | +37.1% | +20.4% | +52.1% | -- |
| Gross Profit Growth (YoY) | -10.9% | -11.3% | +67.0% | -- |
| Operating Income Growth (YoY) | -291.4% | -44.8% | +91.2% | -- |
| **Net Income Growth (YoY)** | -289.1% | -40.9% | +78.4% | -- |
| EPS Growth (YoY) | -184.2% | -46.5% | -77.8% | -- |
| Operating Cash Flow Growth (YoY) | -- | -148.7% | +1994.7% | -- |
| Free Cash Flow Growth (YoY) | -- | -154.4% | +156656.3% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
